Aveanna Healthcare has gained about 0.4% so far this year, outperforming the broader Medical sector which has lost an average of 3.6%. The stock holds a Zacks Rank of 2, or Buy, and its full-year earnings consensus estimate has risen 17.5% over the past quarter. Within the Medical - Outpatient and Home Healthcare industry, which has returned about 9% year-to-date, Aveanna is slightly underperforming. Align Technology, another Medical stock, has returned 7.9% this year and also carries a Zacks Rank of 2.
Aveanna Healthcare Holdings IncStock outperformed sector, holds Zacks Rank 2 (Buy), and full-year earnings consensus estimate rose 17.5% over the past quarter.
Align Technology Inc